Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03418402
Other study ID # 2017-27
Secondary ID 2017-A01640-53
Status Completed
Phase N/A
First received
Last updated
Start date February 8, 2018
Est. completion date July 8, 2020

Study information

Verified date August 2022
Source Assistance Publique Hopitaux De Marseille
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Airseal® is an insufflation management system for laparoscopic surgery which provides stable pneumoperitoneum, continuous smoke evacuation and valve-free access to the abdominal cavity. It allows an optimal exposure with a low-pression pneumoperitoneum, which is rarely possible with our standard insufflation system under a pneumoperitoneum of 12 millimetres of mercury(mmHg). The objective of this study is to compare the use of Airseal® system with a low pression pneumoperitoneum and our standard insufflation system usually used in our center in term of postoperative abdominal pain after laparoscopic hysterectomy for benign disease. This superiority prospective randomized trial is designed to include all patients > 18 years old referred for laparoscopic total hysterectomy for benign disease (with or without uni or bilateral annexectomy). Each patient would be randomized to one of this two following groups : - " Airseal® " group : use of AIRSEAL® to obtain stable low pression laparoscopy with a 8 to 10 mmHg pneumoperitoneum. - " Standard laparoscopy " group : laparoscopy realised with our usual insufflation system and a 12 to 15 mmHg pneumoperitoneum. The primary end point is mean intensity of abdominal pain six hours after the end of surgery (H6), measured by simple numerical scale (ENS). The secondary end points are: - peroperative endpoints : operative time, blood loss, use of additional ways of increasing exposure, peroperative complications, conversion to laparotomy, feeling of the surgeon regarding the difficulty of the surgery (measured by a simple numerical scale) - early postoperative endpoints : intensity of abdominal pain at the entry in recovery room (H0), at twelve hours after the end of surgery (H12), twenty four hours (H24) and forty eight hours (H48) ; intensity of scapular pain at the same times (H0, H6, H12, H24 and H48), need for analgesic administration (regarding to the standardized analgesic protocol), difference in the hemoglobin level before surgery and the first day after, early postoperative complications, necessity of a second surgery and the reason, length of hospital stay. - late postoperative end points : estimated time to return to optimal quality of life, global satisfaction of patients evaluated by the Quality Of Life Questionnaire Short Form 12. It will be estimate that the use of Airseal® will reduce the mean abdominal pain at H6 post operative of 1 point on the simple numerical scale compared to our standard insufflation system, with a standard deviation of 1,5. Type 1 and 2 errors were set to the usual levels of 0,05 and 0,20 respectively (power of 80%). Assuming a 10% withdrawal rate, the sample size would be 80 patients (40 patients in each group).


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date July 8, 2020
Est. primary completion date June 11, 2020
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients at least 18 years old. - Patients who agreed to participate in the study and signed informed consent. - Surgical indication by laparoscopy of total interadnexal hysterectomy or associated with unilateral or bilateral adnexectomy, for benign pathology, without any other associated surgical procedure. - Absence of contraindications to the taking of analgesics provided for in the standardized protocols of analgesia per and post-operative. Exclusion Criteria: - Patients at least 18 years old. - Patients who agreed to participate in the study and signed informed consent. - Surgical indication by laparoscopy of total interadnexal hysterectomy or associated with unilateral or bilateral adnexectomy, for benign pathology, without any other associated surgical procedure. - Absence of contraindications to the taking of analgesics provided for in the standardized protocols of analgesia per and post-operative.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Airseal®
Total laparoscopic hysterectomy: Approach according to the Open-Laparoscopy technique and use of the insufflation system.
Standard insufflator
Standard insufflator

Locations

Country Name City State
France Assistance Publique Hôpitaux de Marseille Marseille

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique Hopitaux De Marseille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of pain by simple numerical scale The primary end point is mean intensity of abdominal pain measured by simple numerical scale. a score of 0 to 10 best describes the importance of the patient's pain. The score 0 corresponds to "no pain". Note 10 is the maximum "pain" imaginable six hours
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06050161 - Evaluating Artisential Laparoscopic Instruments in Gynecologic Surgery N/A
Terminated NCT04081727 - Zip-Stitchâ„¢ for Vaginal Cuff Closure in Laparoscopic Hysterectomy - Safety & Efficacy Study N/A
Recruiting NCT05645809 - Clinical Trial to Evaluate the Safety and Efficacy of MONOFIX® PGCL Suture in Laparoscopic Surgery N/A
Completed NCT04239547 - Effects of Recruitment Maneuver During Intraoperative Period N/A
Completed NCT03144414 - Laparoscopic Assisted Doderlin Vaginal Hysterectomy N/A
Completed NCT03126162 - Postoperative Bladder Testing After Total Laparoscopic Hysterectomy N/A
Completed NCT02908841 - Surgicel Snow in Gynecological Surgery N/A
Completed NCT04972682 - [SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer N/A
Completed NCT02065453 - Disposable Energy Sources and Operating Room Time for Laparoscopic Hysterectomy N/A
Recruiting NCT05826119 - Intravenous Administration of Magnesium Sulfate in Laparoscopic Hysterectomy Cases N/A
Completed NCT04366375 - Pentraxin-3 in Hysterectomy Patients
Completed NCT05690087 - Lidocaine Infusion on Optic Nerve Sheath Diameter in Laparoscopic Hysterectomy in Trendelenburg Position N/A
Completed NCT03350334 - Perioperative Duloxetine for Pain Management After Laparoscopic Hysterectomy N/A
Terminated NCT04725981 - Vaginal Stump Infection After Laparoscopic Hysterectomy N/A
Completed NCT01344499 - Clearance Rate of Peritoneal Fluid After Full Conditioning Pneumoperitoneum N/A
Recruiting NCT05570916 - Zip-Stitch® in Minimally-Invasive Surgery (ZIMS) - Safety & Efficacy in Hysterectomy N/A
Completed NCT01578759 - Effects of Salpingectomy During Laparoscopic Hysterectomy on Ovarian Function N/A